0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Desloratadine Oral Solution Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-0D19455
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Desloratadine Oral Solution Market Research Report 2025
BUY CHAPTERS

Global Desloratadine Oral Solution Market Research Report 2025

Code: QYRE-Auto-0D19455
Report
March 2025
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Desloratadine Oral Solution Market Size

The global market for Desloratadine Oral Solution was valued at US$ 291 million in the year 2024 and is projected to reach a revised size of US$ 362 million by 2031, growing at a CAGR of 3.1% during the forecast period.

Desloratadine Oral Solution Market

Desloratadine Oral Solution Market

Desloratadine Oral Solution is a liquid medication used primarily to treat allergic reactions. It is an antihistamine that works by blocking histamine, a substance in the body that causes allergic symptoms such as sneezing, runny nose, itching, and watery eyes. Desloratadine is the active metabolite of loratadine (another antihistamine), and it is commonly used to relieve the symptoms of seasonal allergies (hay fever) and year-round allergic rhinitis.
North American market for Desloratadine Oral Solution is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Desloratadine Oral Solution is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Desloratadine Oral Solution include Merck Sharp & Dohme, Anhui Xinshiji Pharmaceutical, Beimei Pharmaceutical, Yabao Pharmaceutical, Harbin Sanctity Biological Pharmaceutical, Sinopharm Zhijun, Hefei Amvite Pharmaceutical, Huluwa Pharmaceutical, Avanc Pharma, SHIJIAZHUANG HUAXIN PHARMACEUTICAL, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Desloratadine Oral Solution, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Desloratadine Oral Solution.
The Desloratadine Oral Solution market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Desloratadine Oral Solution market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Desloratadine Oral Solution manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Desloratadine Oral Solution Market Report

Report Metric Details
Report Name Desloratadine Oral Solution Market
Accounted market size in year US$ 291 million
Forecasted market size in 2031 US$ 362 million
CAGR 3.1%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • 0.5mg/ml
  • 0.25mg/ml
Segment by Application
  • Hospital
  • Clinic
  • Pharmacy
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck Sharp & Dohme, Anhui Xinshiji Pharmaceutical, Beimei Pharmaceutical, Yabao Pharmaceutical, Harbin Sanctity Biological Pharmaceutical, Sinopharm Zhijun, Hefei Amvite Pharmaceutical, Huluwa Pharmaceutical, Avanc Pharma, SHIJIAZHUANG HUAXIN PHARMACEUTICAL, Shandong Langnuo Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Desloratadine Oral Solution manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Desloratadine Oral Solution in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Desloratadine Oral Solution Market growing?

Ans: The Desloratadine Oral Solution Market witnessing a CAGR of 3.1% during the forecast period 2025-2031.

What is the Desloratadine Oral Solution Market size in 2031?

Ans: The Desloratadine Oral Solution Market size in 2031 will be US$ 362 million.

Who are the main players in the Desloratadine Oral Solution Market report?

Ans: The main players in the Desloratadine Oral Solution Market are Merck Sharp & Dohme, Anhui Xinshiji Pharmaceutical, Beimei Pharmaceutical, Yabao Pharmaceutical, Harbin Sanctity Biological Pharmaceutical, Sinopharm Zhijun, Hefei Amvite Pharmaceutical, Huluwa Pharmaceutical, Avanc Pharma, SHIJIAZHUANG HUAXIN PHARMACEUTICAL, Shandong Langnuo Pharmaceutical

What are the Application segmentation covered in the Desloratadine Oral Solution Market report?

Ans: The Applications covered in the Desloratadine Oral Solution Market report are Hospital, Clinic, Pharmacy

What are the Type segmentation covered in the Desloratadine Oral Solution Market report?

Ans: The Types covered in the Desloratadine Oral Solution Market report are 0.5mg/ml, 0.25mg/ml

Recommended Reports

Allergy Treatments

Pollen Allergy Drugs

Oral Drug Markets

1 Desloratadine Oral Solution Market Overview
1.1 Product Definition
1.2 Desloratadine Oral Solution by Type
1.2.1 Global Desloratadine Oral Solution Market Value Comparison by Type (2024 VS 2031)
1.2.2 0.5mg/ml
1.2.3 0.25mg/ml
1.3 Desloratadine Oral Solution by Application
1.3.1 Global Desloratadine Oral Solution Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Pharmacy
1.4 Global Desloratadine Oral Solution Market Size Estimates and Forecasts
1.4.1 Global Desloratadine Oral Solution Revenue 2020-2031
1.4.2 Global Desloratadine Oral Solution Sales 2020-2031
1.4.3 Global Desloratadine Oral Solution Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Desloratadine Oral Solution Market Competition by Manufacturers
2.1 Global Desloratadine Oral Solution Sales Market Share by Manufacturers (2020-2025)
2.2 Global Desloratadine Oral Solution Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Desloratadine Oral Solution Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Desloratadine Oral Solution, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Desloratadine Oral Solution, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Desloratadine Oral Solution, Product Type & Application
2.7 Global Key Manufacturers of Desloratadine Oral Solution, Date of Enter into This Industry
2.8 Global Desloratadine Oral Solution Market Competitive Situation and Trends
2.8.1 Global Desloratadine Oral Solution Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Desloratadine Oral Solution Players Market Share by Revenue
2.8.3 Global Desloratadine Oral Solution Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Desloratadine Oral Solution Market Scenario by Region
3.1 Global Desloratadine Oral Solution Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Desloratadine Oral Solution Sales by Region: 2020-2031
3.2.1 Global Desloratadine Oral Solution Sales by Region: 2020-2025
3.2.2 Global Desloratadine Oral Solution Sales by Region: 2026-2031
3.3 Global Desloratadine Oral Solution Revenue by Region: 2020-2031
3.3.1 Global Desloratadine Oral Solution Revenue by Region: 2020-2025
3.3.2 Global Desloratadine Oral Solution Revenue by Region: 2026-2031
3.4 North America Desloratadine Oral Solution Market Facts & Figures by Country
3.4.1 North America Desloratadine Oral Solution Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Desloratadine Oral Solution Sales by Country (2020-2031)
3.4.3 North America Desloratadine Oral Solution Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Desloratadine Oral Solution Market Facts & Figures by Country
3.5.1 Europe Desloratadine Oral Solution Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Desloratadine Oral Solution Sales by Country (2020-2031)
3.5.3 Europe Desloratadine Oral Solution Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Desloratadine Oral Solution Market Facts & Figures by Region
3.6.1 Asia Pacific Desloratadine Oral Solution Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Desloratadine Oral Solution Sales by Region (2020-2031)
3.6.3 Asia Pacific Desloratadine Oral Solution Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Desloratadine Oral Solution Market Facts & Figures by Country
3.7.1 Latin America Desloratadine Oral Solution Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Desloratadine Oral Solution Sales by Country (2020-2031)
3.7.3 Latin America Desloratadine Oral Solution Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Desloratadine Oral Solution Market Facts & Figures by Country
3.8.1 Middle East and Africa Desloratadine Oral Solution Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Desloratadine Oral Solution Sales by Country (2020-2031)
3.8.3 Middle East and Africa Desloratadine Oral Solution Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Desloratadine Oral Solution Sales by Type (2020-2031)
4.1.1 Global Desloratadine Oral Solution Sales by Type (2020-2025)
4.1.2 Global Desloratadine Oral Solution Sales by Type (2026-2031)
4.1.3 Global Desloratadine Oral Solution Sales Market Share by Type (2020-2031)
4.2 Global Desloratadine Oral Solution Revenue by Type (2020-2031)
4.2.1 Global Desloratadine Oral Solution Revenue by Type (2020-2025)
4.2.2 Global Desloratadine Oral Solution Revenue by Type (2026-2031)
4.2.3 Global Desloratadine Oral Solution Revenue Market Share by Type (2020-2031)
4.3 Global Desloratadine Oral Solution Price by Type (2020-2031)
5 Segment by Application
5.1 Global Desloratadine Oral Solution Sales by Application (2020-2031)
5.1.1 Global Desloratadine Oral Solution Sales by Application (2020-2025)
5.1.2 Global Desloratadine Oral Solution Sales by Application (2026-2031)
5.1.3 Global Desloratadine Oral Solution Sales Market Share by Application (2020-2031)
5.2 Global Desloratadine Oral Solution Revenue by Application (2020-2031)
5.2.1 Global Desloratadine Oral Solution Revenue by Application (2020-2025)
5.2.2 Global Desloratadine Oral Solution Revenue by Application (2026-2031)
5.2.3 Global Desloratadine Oral Solution Revenue Market Share by Application (2020-2031)
5.3 Global Desloratadine Oral Solution Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck Sharp & Dohme
6.1.1 Merck Sharp & Dohme Company Information
6.1.2 Merck Sharp & Dohme Description and Business Overview
6.1.3 Merck Sharp & Dohme Desloratadine Oral Solution Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck Sharp & Dohme Desloratadine Oral Solution Product Portfolio
6.1.5 Merck Sharp & Dohme Recent Developments/Updates
6.2 Anhui Xinshiji Pharmaceutical
6.2.1 Anhui Xinshiji Pharmaceutical Company Information
6.2.2 Anhui Xinshiji Pharmaceutical Description and Business Overview
6.2.3 Anhui Xinshiji Pharmaceutical Desloratadine Oral Solution Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Anhui Xinshiji Pharmaceutical Desloratadine Oral Solution Product Portfolio
6.2.5 Anhui Xinshiji Pharmaceutical Recent Developments/Updates
6.3 Beimei Pharmaceutical
6.3.1 Beimei Pharmaceutical Company Information
6.3.2 Beimei Pharmaceutical Description and Business Overview
6.3.3 Beimei Pharmaceutical Desloratadine Oral Solution Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Beimei Pharmaceutical Desloratadine Oral Solution Product Portfolio
6.3.5 Beimei Pharmaceutical Recent Developments/Updates
6.4 Yabao Pharmaceutical
6.4.1 Yabao Pharmaceutical Company Information
6.4.2 Yabao Pharmaceutical Description and Business Overview
6.4.3 Yabao Pharmaceutical Desloratadine Oral Solution Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Yabao Pharmaceutical Desloratadine Oral Solution Product Portfolio
6.4.5 Yabao Pharmaceutical Recent Developments/Updates
6.5 Harbin Sanctity Biological Pharmaceutical
6.5.1 Harbin Sanctity Biological Pharmaceutical Company Information
6.5.2 Harbin Sanctity Biological Pharmaceutical Description and Business Overview
6.5.3 Harbin Sanctity Biological Pharmaceutical Desloratadine Oral Solution Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Harbin Sanctity Biological Pharmaceutical Desloratadine Oral Solution Product Portfolio
6.5.5 Harbin Sanctity Biological Pharmaceutical Recent Developments/Updates
6.6 Sinopharm Zhijun
6.6.1 Sinopharm Zhijun Company Information
6.6.2 Sinopharm Zhijun Description and Business Overview
6.6.3 Sinopharm Zhijun Desloratadine Oral Solution Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Sinopharm Zhijun Desloratadine Oral Solution Product Portfolio
6.6.5 Sinopharm Zhijun Recent Developments/Updates
6.7 Hefei Amvite Pharmaceutical
6.7.1 Hefei Amvite Pharmaceutical Company Information
6.7.2 Hefei Amvite Pharmaceutical Description and Business Overview
6.7.3 Hefei Amvite Pharmaceutical Desloratadine Oral Solution Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Hefei Amvite Pharmaceutical Desloratadine Oral Solution Product Portfolio
6.7.5 Hefei Amvite Pharmaceutical Recent Developments/Updates
6.8 Huluwa Pharmaceutical
6.8.1 Huluwa Pharmaceutical Company Information
6.8.2 Huluwa Pharmaceutical Description and Business Overview
6.8.3 Huluwa Pharmaceutical Desloratadine Oral Solution Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Huluwa Pharmaceutical Desloratadine Oral Solution Product Portfolio
6.8.5 Huluwa Pharmaceutical Recent Developments/Updates
6.9 Avanc Pharma
6.9.1 Avanc Pharma Company Information
6.9.2 Avanc Pharma Description and Business Overview
6.9.3 Avanc Pharma Desloratadine Oral Solution Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Avanc Pharma Desloratadine Oral Solution Product Portfolio
6.9.5 Avanc Pharma Recent Developments/Updates
6.10 SHIJIAZHUANG HUAXIN PHARMACEUTICAL
6.10.1 SHIJIAZHUANG HUAXIN PHARMACEUTICAL Company Information
6.10.2 SHIJIAZHUANG HUAXIN PHARMACEUTICAL Description and Business Overview
6.10.3 SHIJIAZHUANG HUAXIN PHARMACEUTICAL Desloratadine Oral Solution Sales, Revenue and Gross Margin (2020-2025)
6.10.4 SHIJIAZHUANG HUAXIN PHARMACEUTICAL Desloratadine Oral Solution Product Portfolio
6.10.5 SHIJIAZHUANG HUAXIN PHARMACEUTICAL Recent Developments/Updates
6.11 Shandong Langnuo Pharmaceutical
6.11.1 Shandong Langnuo Pharmaceutical Company Information
6.11.2 Shandong Langnuo Pharmaceutical Description and Business Overview
6.11.3 Shandong Langnuo Pharmaceutical Desloratadine Oral Solution Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Shandong Langnuo Pharmaceutical Desloratadine Oral Solution Product Portfolio
6.11.5 Shandong Langnuo Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Desloratadine Oral Solution Industry Chain Analysis
7.2 Desloratadine Oral Solution Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Desloratadine Oral Solution Production Mode & Process Analysis
7.4 Desloratadine Oral Solution Sales and Marketing
7.4.1 Desloratadine Oral Solution Sales Channels
7.4.2 Desloratadine Oral Solution Distributors
7.5 Desloratadine Oral Solution Customer Analysis
8 Desloratadine Oral Solution Market Dynamics
8.1 Desloratadine Oral Solution Industry Trends
8.2 Desloratadine Oral Solution Market Drivers
8.3 Desloratadine Oral Solution Market Challenges
8.4 Desloratadine Oral Solution Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Desloratadine Oral Solution Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Desloratadine Oral Solution Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Desloratadine Oral Solution Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Desloratadine Oral Solution Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Desloratadine Oral Solution Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Desloratadine Oral Solution Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Desloratadine Oral Solution Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Desloratadine Oral Solution Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Desloratadine Oral Solution, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Desloratadine Oral Solution, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Desloratadine Oral Solution, Product Type & Application
 Table 12. Global Key Manufacturers of Desloratadine Oral Solution, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Desloratadine Oral Solution by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Desloratadine Oral Solution as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Desloratadine Oral Solution Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Desloratadine Oral Solution Sales by Region (2020-2025) & (K Units)
 Table 18. Global Desloratadine Oral Solution Sales Market Share by Region (2020-2025)
 Table 19. Global Desloratadine Oral Solution Sales by Region (2026-2031) & (K Units)
 Table 20. Global Desloratadine Oral Solution Sales Market Share by Region (2026-2031)
 Table 21. Global Desloratadine Oral Solution Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Desloratadine Oral Solution Revenue Market Share by Region (2020-2025)
 Table 23. Global Desloratadine Oral Solution Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Desloratadine Oral Solution Revenue Market Share by Region (2026-2031)
 Table 25. North America Desloratadine Oral Solution Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Desloratadine Oral Solution Sales by Country (2020-2025) & (K Units)
 Table 27. North America Desloratadine Oral Solution Sales by Country (2026-2031) & (K Units)
 Table 28. North America Desloratadine Oral Solution Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Desloratadine Oral Solution Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Desloratadine Oral Solution Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Desloratadine Oral Solution Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Desloratadine Oral Solution Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Desloratadine Oral Solution Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Desloratadine Oral Solution Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Desloratadine Oral Solution Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Desloratadine Oral Solution Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Desloratadine Oral Solution Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Desloratadine Oral Solution Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Desloratadine Oral Solution Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Desloratadine Oral Solution Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Desloratadine Oral Solution Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Desloratadine Oral Solution Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Desloratadine Oral Solution Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Desloratadine Oral Solution Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Desloratadine Oral Solution Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Desloratadine Oral Solution Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Desloratadine Oral Solution Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Desloratadine Oral Solution Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Desloratadine Oral Solution Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Desloratadine Oral Solution Sales (K Units) by Type (2020-2025)
 Table 51. Global Desloratadine Oral Solution Sales (K Units) by Type (2026-2031)
 Table 52. Global Desloratadine Oral Solution Sales Market Share by Type (2020-2025)
 Table 53. Global Desloratadine Oral Solution Sales Market Share by Type (2026-2031)
 Table 54. Global Desloratadine Oral Solution Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Desloratadine Oral Solution Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Desloratadine Oral Solution Revenue Market Share by Type (2020-2025)
 Table 57. Global Desloratadine Oral Solution Revenue Market Share by Type (2026-2031)
 Table 58. Global Desloratadine Oral Solution Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Desloratadine Oral Solution Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Desloratadine Oral Solution Sales (K Units) by Application (2020-2025)
 Table 61. Global Desloratadine Oral Solution Sales (K Units) by Application (2026-2031)
 Table 62. Global Desloratadine Oral Solution Sales Market Share by Application (2020-2025)
 Table 63. Global Desloratadine Oral Solution Sales Market Share by Application (2026-2031)
 Table 64. Global Desloratadine Oral Solution Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Desloratadine Oral Solution Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Desloratadine Oral Solution Revenue Market Share by Application (2020-2025)
 Table 67. Global Desloratadine Oral Solution Revenue Market Share by Application (2026-2031)
 Table 68. Global Desloratadine Oral Solution Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Desloratadine Oral Solution Price (US$/Unit) by Application (2026-2031)
 Table 70. Merck Sharp & Dohme Company Information
 Table 71. Merck Sharp & Dohme Description and Business Overview
 Table 72. Merck Sharp & Dohme Desloratadine Oral Solution Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Merck Sharp & Dohme Desloratadine Oral Solution Product
 Table 74. Merck Sharp & Dohme Recent Developments/Updates
 Table 75. Anhui Xinshiji Pharmaceutical Company Information
 Table 76. Anhui Xinshiji Pharmaceutical Description and Business Overview
 Table 77. Anhui Xinshiji Pharmaceutical Desloratadine Oral Solution Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Anhui Xinshiji Pharmaceutical Desloratadine Oral Solution Product
 Table 79. Anhui Xinshiji Pharmaceutical Recent Developments/Updates
 Table 80. Beimei Pharmaceutical Company Information
 Table 81. Beimei Pharmaceutical Description and Business Overview
 Table 82. Beimei Pharmaceutical Desloratadine Oral Solution Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Beimei Pharmaceutical Desloratadine Oral Solution Product
 Table 84. Beimei Pharmaceutical Recent Developments/Updates
 Table 85. Yabao Pharmaceutical Company Information
 Table 86. Yabao Pharmaceutical Description and Business Overview
 Table 87. Yabao Pharmaceutical Desloratadine Oral Solution Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Yabao Pharmaceutical Desloratadine Oral Solution Product
 Table 89. Yabao Pharmaceutical Recent Developments/Updates
 Table 90. Harbin Sanctity Biological Pharmaceutical Company Information
 Table 91. Harbin Sanctity Biological Pharmaceutical Description and Business Overview
 Table 92. Harbin Sanctity Biological Pharmaceutical Desloratadine Oral Solution Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Harbin Sanctity Biological Pharmaceutical Desloratadine Oral Solution Product
 Table 94. Harbin Sanctity Biological Pharmaceutical Recent Developments/Updates
 Table 95. Sinopharm Zhijun Company Information
 Table 96. Sinopharm Zhijun Description and Business Overview
 Table 97. Sinopharm Zhijun Desloratadine Oral Solution Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Sinopharm Zhijun Desloratadine Oral Solution Product
 Table 99. Sinopharm Zhijun Recent Developments/Updates
 Table 100. Hefei Amvite Pharmaceutical Company Information
 Table 101. Hefei Amvite Pharmaceutical Description and Business Overview
 Table 102. Hefei Amvite Pharmaceutical Desloratadine Oral Solution Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Hefei Amvite Pharmaceutical Desloratadine Oral Solution Product
 Table 104. Hefei Amvite Pharmaceutical Recent Developments/Updates
 Table 105. Huluwa Pharmaceutical Company Information
 Table 106. Huluwa Pharmaceutical Description and Business Overview
 Table 107. Huluwa Pharmaceutical Desloratadine Oral Solution Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Huluwa Pharmaceutical Desloratadine Oral Solution Product
 Table 109. Huluwa Pharmaceutical Recent Developments/Updates
 Table 110. Avanc Pharma Company Information
 Table 111. Avanc Pharma Description and Business Overview
 Table 112. Avanc Pharma Desloratadine Oral Solution Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Avanc Pharma Desloratadine Oral Solution Product
 Table 114. Avanc Pharma Recent Developments/Updates
 Table 115. SHIJIAZHUANG HUAXIN PHARMACEUTICAL Company Information
 Table 116. SHIJIAZHUANG HUAXIN PHARMACEUTICAL Description and Business Overview
 Table 117. SHIJIAZHUANG HUAXIN PHARMACEUTICAL Desloratadine Oral Solution Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. SHIJIAZHUANG HUAXIN PHARMACEUTICAL Desloratadine Oral Solution Product
 Table 119. SHIJIAZHUANG HUAXIN PHARMACEUTICAL Recent Developments/Updates
 Table 120. Shandong Langnuo Pharmaceutical Company Information
 Table 121. Shandong Langnuo Pharmaceutical Description and Business Overview
 Table 122. Shandong Langnuo Pharmaceutical Desloratadine Oral Solution Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Shandong Langnuo Pharmaceutical Desloratadine Oral Solution Product
 Table 124. Shandong Langnuo Pharmaceutical Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Desloratadine Oral Solution Distributors List
 Table 128. Desloratadine Oral Solution Customers List
 Table 129. Desloratadine Oral Solution Market Trends
 Table 130. Desloratadine Oral Solution Market Drivers
 Table 131. Desloratadine Oral Solution Market Challenges
 Table 132. Desloratadine Oral Solution Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Desloratadine Oral Solution
 Figure 2. Global Desloratadine Oral Solution Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Desloratadine Oral Solution Market Share by Type: 2024 & 2031
 Figure 4. 0.5mg/ml Product Picture
 Figure 5. 0.25mg/ml Product Picture
 Figure 6. Global Desloratadine Oral Solution Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Desloratadine Oral Solution Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Pharmacy
 Figure 11. Global Desloratadine Oral Solution Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Desloratadine Oral Solution Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Desloratadine Oral Solution Sales (2020-2031) & (K Units)
 Figure 14. Global Desloratadine Oral Solution Average Price (US$/Unit) & (2020-2031)
 Figure 15. Desloratadine Oral Solution Report Years Considered
 Figure 16. Desloratadine Oral Solution Sales Share by Manufacturers in 2024
 Figure 17. Global Desloratadine Oral Solution Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Desloratadine Oral Solution Players: Market Share by Revenue in Desloratadine Oral Solution in 2024
 Figure 19. Desloratadine Oral Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Desloratadine Oral Solution Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Desloratadine Oral Solution Sales Market Share by Country (2020-2031)
 Figure 22. North America Desloratadine Oral Solution Revenue Market Share by Country (2020-2031)
 Figure 23. United States Desloratadine Oral Solution Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Desloratadine Oral Solution Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Desloratadine Oral Solution Sales Market Share by Country (2020-2031)
 Figure 26. Europe Desloratadine Oral Solution Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Desloratadine Oral Solution Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Desloratadine Oral Solution Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Desloratadine Oral Solution Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Desloratadine Oral Solution Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Desloratadine Oral Solution Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Desloratadine Oral Solution Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Desloratadine Oral Solution Revenue Market Share by Region (2020-2031)
 Figure 34. China Desloratadine Oral Solution Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Desloratadine Oral Solution Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Desloratadine Oral Solution Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Desloratadine Oral Solution Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Desloratadine Oral Solution Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Desloratadine Oral Solution Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Desloratadine Oral Solution Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Desloratadine Oral Solution Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Desloratadine Oral Solution Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Desloratadine Oral Solution Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Desloratadine Oral Solution Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Desloratadine Oral Solution Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Colombia Desloratadine Oral Solution Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Desloratadine Oral Solution Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Desloratadine Oral Solution Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Desloratadine Oral Solution Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Desloratadine Oral Solution Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Desloratadine Oral Solution Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Desloratadine Oral Solution by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Desloratadine Oral Solution by Type (2020-2031)
 Figure 54. Global Desloratadine Oral Solution Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Desloratadine Oral Solution by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Desloratadine Oral Solution by Application (2020-2031)
 Figure 57. Global Desloratadine Oral Solution Price (US$/Unit) by Application (2020-2031)
 Figure 58. Desloratadine Oral Solution Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19B19893
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30B3636
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3H1702
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13C3384
Wed Sep 10 00:00:00 UTC 2025

Add to Cart